Answers are grounded in this paper and cite their sources.
In the context of prenatal diagnostic testing, chromosomal microarray analysis identified additional, clinically significant cytogenetic information as compared with karyotyping and was equally efficacious in identifying aneuploidies and unbalanced rearrangements but did not identify balanced translocations and triploidies. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; ClinicalTrials.gov number, NCT01279733.).
No takes yet. Share an insight, caveat, or question.
Wapner et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: